P280-technetium-99m targeting platelet receptor GPIIb/IIIa data

DITI announced that several studies presented at the meeting of the Society of Nuclear Medicine in San Antonio, Texas, showed the accuracy of the imaging agent. An NDA will be submitted this year.

In one trial in 39 patients, a combination of two sets of images, obtained at 60 and 120 minutes, gave the best accuracy, 87.2 percent, compared to 71.8 percent at 10 minutes and 60 minutes, and 81.6 percent at 120 minutes. In another study in 125 evaluable patients, the agreement rate, sensitivity, and specificity of P280 was 80, 92, and 72 percent in comparison with contrast venography. ...